Vascular endothelial cell growth factor antagonists and uses thereof
AssigneeGenentech, Inc.
InventorsNicholas Van Bruggen, Napoleone Ferrara
Life of this patent
Estimating the term…
Abstract
The present invention provides vascular endothelial cell growth factor (VEGF) antagonists and methods of using VEGF antagonists. VEGF antagonists contemplated by the invention include VEGF antibodies and VEGF receptor fusion proteins. Methods of treating edema and stroke using VEGF antagonists are also provided.
Claims22
A method of treating a mammal having edema comprising administering to said mammal an effective amount of hVEGF antagonist, wherein said hVEGF antagonist comprises an hVEGF receptor fusion protein.
-11. (canceled)
A method of treating a mammal having or having undergone a stroke, comprising administering to said mammal an effective amount of hVEGF antagonist, wherein said hVEGF antagonist comprises an hVEGF receptor fusion protein.
-19. (canceled)
-29. (canceled)
A method of reducing cerebral edema due to a non-neoplastic condition in a mammal, comprising administering to said mammal a hVEGF antagonist in an amount effective to reduce the volume of cerebral edema, wherein said hVEGF antagonist comprises an hVEGF receptor fusion protein.
-36. (canceled)
Dependencies are inferred from the claim text.